Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 6/2000

01-11-2000 | Originales

Small cell lung cancer in the elderly: factors influencing treatment decision and effect on survival

Authors: Inmaculada Maestu, Miguel Pastor, Jorge Aparicio, José Gómez-Codina, Amparo Oltra, Constantino Herranz, Joaquín Montalar, Blanca Munárriz, Gaspar Reynés

Published in: Clinical and Translational Oncology | Issue 6/2000

Login to get access
Metadata
Title
Small cell lung cancer in the elderly: factors influencing treatment decision and effect on survival
Authors
Inmaculada Maestu
Miguel Pastor
Jorge Aparicio
José Gómez-Codina
Amparo Oltra
Constantino Herranz
Joaquín Montalar
Blanca Munárriz
Gaspar Reynés
Publication date
01-11-2000
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 6/2000
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/BF02979592

Other articles of this Issue 6/2000

Clinical and Translational Oncology 6/2000 Go to the issue

EditorialNotes

Editorial

Correspondencia

Chemoresistance can limit the success of radical surgery followed by early postoperative intraperitoneal chemotherapy in gastric carcinoma

Originales

Factores pronósticos e indicaciones quirÚrgicas en las metástasis hepáticas de carcinoma colorrectal

Correspondencia

Chemoresistance can limit the success of radical surgery followed by early postoperative intraperitoneal chemotherapy in gastric carcinoma (reply)

Crítica de libros

Cáncer incidence and mortality in Spain: Patterns and trends. Incidencia y mortalidad por cáncer en España: patrones y tendencias

Notas Clínicas

Meningeal carcinomatosis as a cause of partially reversible blindness
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits